Steven Song, MD
Cardiovascular Disease · Fremont, CANPI 1417342312
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,789 of the $8,888 with a category attached, or 65.1%. Medtronic accounts for 62.7% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $6,972 and has fallen 99.7% since, to $20 in 2025.
Across 87 payments — averaging $102.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Medical Device Business Services, Inc.$2K
- Abbott$1K
- Biosense Webster, Inc.$250
- Biotronik Inc.$148
- Boston Scientific$123
- plus $153 from 4 others
Across 2 payments — averaging $75,001 each. An ownership or investment interest held by the physician or an immediate family member.
- Capsovision, Inc.$150K
What the payments were for
- Travel & lodging$5,78965%
- Food & beverage$3,07935%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 46 | $5,574 |
| Medical Device Business Services, Inc. | 4 | $1,606 |
| Abbott | 26 | $1,034 |
| Biosense Webster, Inc. | 5 | $250 |
| Biotronik Inc. | 1 | $148 |
| Boston Scientific | 1 | $123 |
| Atricure, Inc. | 1 | $95 |
| Novo Nordisk | 1 | $22 |
| Bayer | 1 | $20 |
| Cook Medical LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$1,731
- AMPLIA MRI QUAD CRT-D SURESCAN$1,145
- ADVISA DR MRI SURESCAN$527
- AVEIR$424
- QUADRA ASSURA$181
- Selectra$148
- BioMonitor$148
- ENSITE PRECISION$134
- Watchman$123
- COBALT DR MRI SURESCAN$106
- Micra$105
How this compares
$8,888 in reported general payments places this provider in the 75th percentile of 2,184 cardiovascular disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $28,981 |
| Amiodarone Hcl | 12 | $945 |
| Metoprolol Succinate | 35 | $458 |
| Rosuvastatin Calcium | 16 | $374 |
| Amlodipine Besylate | 52 | $284 |
| Atorvastatin Calcium | 21 | $114 |
| ClopidogrelClopidogrel Bisulfate | 15 | $94 |
| Hydralazine Hcl | 13 | $89 |
| Losartan Potassium | 21 | $88 |
| Hydrochlorothiazide | 18 | $48 |
| Metoprolol Tartrate | 14 | $36 |
| Lisinopril | 14 | $22 |
| Furosemide | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Fremont
- Rajesh SuriFremont$220K
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
- Matthew BudoffTorrance$3.6M
- Eric Topolla Jolla$2.2M
- Cathleen Bairey-MerzLos Angeles$1.2M
- Gagan SinghSacramento$1.2M
- Pam Taubla Jolla$1.2M
- Wilber SuStanford$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.